Gefitinib in non-small cell lung cancer

By Tamura Kenji   Fukuoka Masahiro  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 985-993

Informa Healthcare

Access to resources Recommend Favorite

Overview of the Tolerability of Gefitinib (IRESSA™) Monotherapy: Clinical Experience in Non-Small-Cell Lung Cancer

By Beverley Forsythe   Karen Faulkner  

Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. : 1081-1092

Adis International

Access to resources Recommend Favorite

Gefitinib is an effective treatment for patients with non-small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor

By  

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Gefitinib: A Review of its Use in the Management of Advanced Non-Small-Cell Lung Cancer

By James E. Frampton   Stephanie E. Easthope  

Drugs, Vol. 64, Iss. 21, 2004-01 ,pp. : 2475-2492

Adis International

Access to resources Recommend Favorite

Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status

By Chang Gee-Chen   Chen Kun-Chieh   Yang Tsung-Ying   Yin Ming-Chang   Lin Ching-Pei   Kuo Benjamin Ing-Tiau   Hsu Jeng-Yuan  

Investigational New Drugs, Vol. 23, Iss. 1, 2005-01 ,pp. : 73-77

Springer Publishing Company

Access to resources Recommend Favorite